In This Issue
Targeting Schizophrenia Research to Patient Outcomes
Understanding the Glass Ceiling for Functional Outcome in Schizophrenia
Stimulant Medications
Are We Still Talking to Our Patients With Schizophrenia?
Cognitive Behavior Therapy for Schizophrenia
A Tension to Detail
The Schizophrenia Prodrome
The Development of the Self in the Era of the Internet and Role-Playing Fantasy Games
Abraham Arden Brill, 1874–1948
PET Study Examining Pharmacokinetics, Detection and Likeability, and Dopamine Transporter Receptor Occupancy of Short- and Long-Acting Oral Methylphenidate
A PET Study Evaluating Dopamine D2 Receptor Occupancy for Long-Acting Injectable Risperidone
A Randomized, Double-Blind, Placebo-Controlled Study of Risperidone Maintenance Treatment in Children and Adolescents With Disruptive Behavior Disorders
Barriers to Employment for People With Schizophrenia
Determinants of Real-World Functional Performance in Schizophrenia Subjects
The Schizophrenia Cognition Rating Scale
Prognostic Variables at Intake and Long-Term Level of Function in Schizophrenia
Impairment in the Specificity of Emotion Processing in Schizophrenia
Social Perception as a Mediator of the Influence of Early Visual Processing on Functional Status in Schizophrenia
Functional and Structural Deficits in Brain Regions Subserving Face Perception in Schizophrenia
Abnormalities of Thalamic Activation and Cognition in Schizophrenia
Sex Differences in Language Dysfunction in Schizophrenia
Regional Brain Morphometry in Patients With Schizophrenia or Bipolar Disorder and Their Unaffected Relatives
Negative Signs and Symptoms Secondary to Antipsychotics
Sildenafil in the Treatment of Antipsychotic-Induced Erectile Dysfunction
Assessment of Therapeutic Misconception in Older Schizophrenia Patients With a Brief Instrument
Association Between the CCR5 32-bp Deletion Allele and Late Onset of Schizophrenia
Improving the Accuracy of the Diagnosis of Schizophrenia by Means of Virtual Reality
Association of Schizophrenia and Autoimmune Diseases
DRD2 Promoter Region Variation as a Predictor of Sustained Response to Antipsychotic Medication in First-Episode Schizophrenia Patients
Dysbindin Genotype and Negative Symptoms in Schizophrenia
BDNF Val66Met Polymorphism and GAD67 mRNA Expression in the Prefrontal Cortex of Subjects With Schizophrenia
No Evidence for an Effect of COMT Val158Met Genotype on Executive Function in Patients With 22q11 Deletion Syndrome
Cellular Basis of Reduced Cortical Reelin Expression in Schizophrenia
Antisaccade Performance in Monozygotic Twins Discordant for Schizophrenia
Sudden Akathisia After a Ziprasidone Dose Reduction
Psychosis Related to Ropinirole
Munchausen's Syndrome With 20-Year Follow-Up
Neuroleptic Malignant Syndrome Related to a Switch to Perospirone and Anticholinergic Withdrawal
Trimipramine for Refractory Panic Attacks
Euphorigenic and Abusive Properties of Modafinil
Osteoporosis and Schizophrenia
Lithium and Suicidality Revisited
Lithium and Suicidality Revisited
Risperidone for the Core Symptom Domains of Autism
Risperidone for the Core Symptom Domains of Autism
Chronic Stress and Adaptation
Chronic Stress and Adaptation
Chronic Stress and Adaptation
The CATIE Study
The CATIE Study
The CATIE Study
Correction
Divided Minds
The American Psychiatric Publishing Textbook of Personality Disorders
Brain Fiction
Offender Profiling
Cognitive Neuroscience of Aging
Books Received